Drawing for GREY MATTERS

USPTO serial 79286125

GREY MATTERS

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
RONCORONI, LAUREN R
Law office
TMEG LAW OFFICE 109

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Need help with GREY MATTERS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bradley M. Stohry

Bradley M. Stohry Reichel Stohry Dean LLP6151 Central Ave.Indianapolis, IN 46220United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software for creating, receiving, manipulating, editing, displaying, storing and organising information, text, data, graphics and images for use in the assessment and diagnosis of brain conditions and brain disease; downloadable computer software for the diagnosis and detection of brain conditions and disease; downloadable computer applications for creating, receiving, manipulating, editing, displaying, storing and organising information, text, data, graphics and images for use in the assessment and diagnosis of brain conditions and brain disease; downloadable computer applications for the diagnosis and detection of brain conditions and disease; downloadable computer software for database management for use in the assessment and diagnosis of brain conditions and brain disease; electronic databases, namely electronic database for the storage of information relating to the assessment and diagnosis of brain conditions and brain disease recorded on computer media; computer databases, namely downloadable electronic databases for the storage of information relating to the assessment and diagnosis of brain conditions and brain disease; downloadable electronic publications, namely, digital patient reports, journals, magazines and newsletters relating to the assessment and diagnosis of brain conditions and brain disease; downloadable computer programs for creating, receiving, manipulating, editing, displaying, storing and organising information, text, data, graphics and images for use in the assessment and diagnosis of brain conditions and brain disease; downloadable computer programs for the diagnosis and detection of brain conditions and disease; downloadable medical diagnostic software for the assessment and diagnosis of brain conditions and brain disease; downloadable diagnostic computer software for the detection of brain conditions and disease; downloadable computer software relating to the medical and healthcare field for the assessment and diagnosis of brain conditions and brain disease; downloadable medical software for the assessment and diagnosis of brain conditions and brain disease; downloadable medical diagnosis, detection and assessment software for the assessment and diagnosis of brain conditions and brain disease; downloadable medical imaging software for the assessment and diagnosis of brain conditions and brain disease; computer documents, namely downloadable documents in the field of the assessment and diagnosis of brain conditions and brain disease provided via a website; computer documentation in electronic form, namely downloadable documents in the field of the assessment and diagnosis of brain conditions and brain disease provided via a website; structural parts and fittings for all of the aforesaid goodsACTIVE—
042Technological services for medical purposes, namely software as a service (SAAS) services featuring software for use in the assessment and diagnosis of brain conditions and brain disease and scientific research services for medical purposes; laboratory testing of brain tissue samples; laboratory research services in the field of the assessment and diagnosis of brain conditions and brain disease; laboratory analysis in the field of the assessment and diagnosis of brain conditions and brain disease; analytic laboratory services in the field of the assessment and diagnosis of brain conditions and brain disease; medical research in the field of the assessment and diagnosis of brain conditions and brain disease; medical laboratories in the field of the assessment and diagnosis of brain conditions and brain disease; medical sampling services, namely providing laboratory testing of brain tissue samples; healthcare and medical research and development in the field of the assessment and diagnosis of brain conditions and brain disease; clinical research in the field of the assessment and diagnosis of brain conditions and brain disease; conducting clinical trials for others in the field of the assessment and diagnosis of brain conditions and brain disease; providing information on clinical trial studies in the field of the assessment and diagnosis of brain conditions and brain disease; information technology consultancy services for the healthcare and medical industries, namely in the field of the assessment and diagnosis of brain conditions and brain disease; providing information on computer technology and programming via a website, namely in the field of the assessment and diagnosis of brain conditions and brain disease; electronic storage of medical and healthcare information and records; computer programming in the medical and healthcare field, namely in the field of the assessment and diagnosis of brain conditions and brain disease; design and development of medical and healthcare diagnostic apparatus, namely in the field of the assessment and diagnosis of brain conditions and brain disease; design and development of computer software for use with medical and healthcare technology, namely for the assessment and diagnosis of brain conditions and brain disease; providing scientific information in the field of medical disorders and their treatment, namely in the field of the assessment and diagnosis of brain conditions and brain disease; writing of computer programs for medical and healthcare applications, namely in the field of the assessment and diagnosis of brain conditions and brain disease; providing medical and scientific research information in the field of pharmaceuticals and clinical trials, namely in relation to the assessment and diagnosis of brain conditions and brain disease; services for the preparation of scientific and technical reports, namely compiling data for research purposes in the field of the assessment and diagnosis of brain conditions and brain disease; compilation of scientific and technical reports, namely compiling data for research purposes in the field of the assessment and diagnosis of brain conditions and brain disease; design services, namely design for others of computer software for use in the assessment and diagnosis of brain conditions and brain disease; design for others of models for use in the assessment and diagnosis of brain conditions and brain disease; design for others of 3D models for use in the assessment and diagnosis of brain conditions and brain disease; information, advisory and consultancy services in relation to all of the aforementioned servicesACTIVE—
044Performing diagnosis and detection of medical conditions and disease in the field of the assessment and diagnosis of brain conditions and brain disease; performing medical diagnosis and detection of brain conditions and disease; medical and health screening, testing and analysis in the field of the assessment and diagnosis of brain conditions and brain disease; conducting of health assessments, examinations and surveys in the nature of assessments for the diagnosis and detection of brain conditions and disease; medical imaging for the diagnosis and detection of brain conditions and disease; medical analysis services for the assessment and diagnosis of brain conditions and brain disease; analysis and assessment of medical images and scans for the diagnosis and detection of brain conditions and disease; medical testing for the diagnosis and detection of brain conditions and disease; medical services for the diagnosis and detection of brain conditions and disease; services for the preparation, compilation and issuing of medical reports, namely providing medical information to patients in the field of the assessment and diagnosis of brain conditions and brain disease; services for the preparation, compilation and issuing of medical reports, namely providing medical information to patients in the form of reports in the field of brain conditions and disease; provision of medical information in the field of brain conditions and disease; information, advisory and consultancy services in relation to all of the aforementioned servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (GNRN): A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

DateCodeEventWhat it means
May 20, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 20, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 20, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 3, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Oct 30, 2025ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jul 13, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 6, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 3, 2025ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Dec 29, 2023RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 30, 2023RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
May 31, 2022RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Nov 15, 2021OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 27, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 27, 2021OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 25, 2021RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Apr 16, 2021GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 16, 2021GNSLLETTER OF SUSPENSION E-MAILED—
Apr 16, 2021CNSLSUSPENSION LETTER WRITTEN—
Jan 22, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 22, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 22, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 7, 2020RFNTREFUSAL PROCESSED BY IB—
Jul 22, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 22, 2020RFRRREFUSAL PROCESSED BY MPU—
Jun 9, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 8, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 30, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
May 26, 2020DOCKASSIGNED TO EXAMINER—
May 26, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 21, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance